Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Jane Sneyd

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Causes & Control : CCC|May 15, 2008
Ethnic differences in prostate cancer survival in New Zealand: a national studyMary Jane Sneyd
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2003
Skin Phenotype and the Impact of Surveillance on Melanoma in New ZealandMary Jane Sneyd
Australian and New Zealand Journal of Public Health|August 9, 2018
The presenting features of melanoma in New Zealand: implications for earlier detectionYvonne Nartey, Mary Jane Sneyd
Journal of the American Society of Cytopathology|May 3, 2019
HPV screening, invasive cervical cancer and screening policy in AustraliaBrian Cox, Mary Jane Sneyd
The New Zealand Medical Journal|December 7, 2011
A regional non-melanoma skin cancer (NMSC) collection as part of the National Cancer RegistryBrian Cox, Mary Jane Sneyd
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2009
Melanoma in Maori, Asian, and Pacific peoples in New ZealandMary Jane Sneyd, Brian Cox
The New Zealand Medical Journal|November 13, 2013
Bowel cancer screening in New ZealandBrian Cox, Mary Jane Sneyd
International Journal of Epidemiology|November 1, 2011
Commentary: decreasing response rates require investigators to quantify and report the impact of selection bias in case-control studiesMary Jane Sneyd, Brian Cox
The New Zealand Medical Journal|February 14, 2012
Support for Associate Professor Barendregt's stance against PSA testing of asymptomatic menBrian Cox, Mary Jane Sneyd
Journal of the American Society of Cytopathology|May 3, 2019
Response to Smith et alBrian Cox, Mary Jane Sneyd
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Causes & Control : CCC|May 15, 2008
Ethnic differences in prostate cancer survival in New Zealand: a national studyMary Jane Sneyd
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2003
Skin Phenotype and the Impact of Surveillance on Melanoma in New ZealandMary Jane Sneyd
Australian and New Zealand Journal of Public Health|August 9, 2018
The presenting features of melanoma in New Zealand: implications for earlier detectionYvonne Nartey, Mary Jane Sneyd
Journal of the American Society of Cytopathology|May 3, 2019
HPV screening, invasive cervical cancer and screening policy in AustraliaBrian Cox, Mary Jane Sneyd
The New Zealand Medical Journal|December 7, 2011
A regional non-melanoma skin cancer (NMSC) collection as part of the National Cancer RegistryBrian Cox, Mary Jane Sneyd
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2009
Melanoma in Maori, Asian, and Pacific peoples in New ZealandMary Jane Sneyd, Brian Cox
The New Zealand Medical Journal|November 13, 2013
Bowel cancer screening in New ZealandBrian Cox, Mary Jane Sneyd
International Journal of Epidemiology|November 1, 2011
Commentary: decreasing response rates require investigators to quantify and report the impact of selection bias in case-control studiesMary Jane Sneyd, Brian Cox
The New Zealand Medical Journal|February 14, 2012
Support for Associate Professor Barendregt's stance against PSA testing of asymptomatic menBrian Cox, Mary Jane Sneyd
Journal of the American Society of Cytopathology|May 3, 2019
Response to Smith et alBrian Cox, Mary Jane Sneyd
Pageof 3